Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 1, 2013, Pages 139-148

  Kristl, Julijana ^a   Plajnšek, Karmen Teskač ^a   Kreft, Mateja Erdani ^a   Janković, Biljana ^a   Kocbek, Petra ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Drug delivery; Fluorescent probes; Intercellular transfer; Intracellular location; Nanotechnology; Tunneling nanotubes

Indexed keywords

7 (DIETHYLAMINO) 2 OXO N TETRADECYL 2H CHROMENE 3 CARBOXAMIDE; FLUORESCENT DYE; NANOTUBE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLUORESCENCE; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR SIGNALING; MITOCHONDRION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS;

EID: 84885055866     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.04.013     Document Type: Article

References (58)

1. Abounit, S., Zurzolo, C., 2012. Wiring through tunneling nanotubes-from electrical signals to organelle transfer. J. Cell Sci. 125, 1089-1098.
2. Ahlin, P., Kristl, J., Smid-Korbar, J., 1998. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharm. 48, 257-267.
3. Caddeo, C., Teskač, K., Sinico, C., Kristl, J., 2008. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int. J. Pharm. 363, 183-191.
4. Cavalli, R., Donalisio, M., Civra, A., Ferruti, P., Ranucci, E., Trotta, F., Lembo, D., 2009. Enhanced antiviral activity of Acyclovir loaded into β-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles. J. Control. Rel. 137, 116-122.
5. Chauveau, A., Aucher, A., Eissmann, P., Vivier, E., Davis, D.M., 2010. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc. Natl. Acad. Sci. USA 107, 5545-5550.
6. Chittasupho, C., Xie, S.K., Baoum, A., Yakovleva, T., Siahaan, T.J., Berkland, C.J., 2009. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci. 37, 141-150.
7. Desai, M.P., Labhasetawar, V., Walter, E., Levy, R.J., Amidon, G.L., 1997. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14, 1568-1573. (Pubitemid 28009208)
8. Ferrati, S., Shamsudeen, S., Summers, H.D., Rees, P., Abbey, J.V., Schmulen, J., Liu, X., Wong, S.T., Bean, A.J., Ferrari, M., Serda, R.E., 2012. Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 8, 3151-3160.
9. Gerdes, H.H., Carvalho, R.N., 2008. Intercellular transfer mediated by tunneling nanotubes. Curr. Opin. Cell Biol. 20, 470-475.
10. Gerdes, H.H., Rustom, A., Wang, X., in press. Tunneling nanotubes, an emerging intercellular communication route in development. Mech. Dev. Article, http://dx.doi.org/10.1016/j.mod.2012.11.006.
11. Gumbleton, M., Stephens, D.J., 2005. Coming out of the dark: the evolving role of fluorescence imaging in drug delivery research. Adv. Drug Deliv. Rev. 57, 5-15. (Pubitemid 39424061)
12. Gurke, S., Barroso, J.F.V., 2008. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem. Cell Biol. 129, 539-550.
13. Harush-Frenkel, O., Debotton, N., Benita, S., Altschuler, Y., 2007. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun. 353, 26-32. (Pubitemid 44958337)
14. Heller, A., Brockhoff, G., Goepferich, A., 2012. Targeting drugs to mitochondria. Eur. J. Pharm. Biopharm. 82, 1-18.
15. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2003. Physico-chemical stability of colloidal lipid particles. Biomaterials 24, 4283-4300. (Pubitemid 36814076)
16. Hillaireau, H., Couvreur, P., 2009. Nanocarriers' entery into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873-2896.
17. Huang, J.G., Leshuk, T., Gu, F.X., 2011. Emerging nanomaterials for targeting subcellular organelles. Nano Today 6, 478-492.
18. Jepson, M.A., 2005. Advances in fluorescence imaging: opportunities for pharmaceutical science. Adv. Drug Deliv. Rev. 57, 1-4. (Pubitemid 39424060)
19. Kiely, J.D., Bonnell, D.A., 1997. Quantification of topographic structure by scanning probe microscopy. J. Vac. Sci. Techn. B 15, 1483-1493. (Pubitemid 127629143)
20. Kimura, S., Hase, K., Ohno, H., 2012. Tunneling nanotubes: emerging view of their molecular components and formation mechanisms. Exp. Cell Res. 318, 1699-1706.
21. Kimura, S., Hase, K., Ohno, H., 2013. The molecular basis of induction and formation of tunneling nanotubes. Cell Tissue Res. 352, 67-76.
22. Kirmizis, D., Logothetidis, S., 2010. Atomic force microscopy probing in the measurement of cell mechanics. Int. J. Nanomedicine 5, 137-145.
23. Kocbek, P., Teskač, K., Erdani Kreft, M., Kristl, J., 2010. Toxicological aspects of longterm treatment of keratinocytes with ZnO and TiO2 nanoparticles. Small 6, 1908-1917.
24. Kostarelos, K., 2003. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv. Colloid Interface Sci. 106, 147-168.
25. Kristl, J., Teskač, K., Caddeo, C., Abramović, Z., Šentjurc, M., 2009. Improvements of cellular stress response on resveratrol in liposomes. Eur. J. Pharm. Biopharm. 73, 253-259.
26. Kristl, J., Teskač, K., Milek, M., Mlinaric-Rascan, I., 2008. Surface active stabilizer tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells. Toxicol. Appl. Pharmacol. 232, 218-225.
27. Kruth, H.S., Chang, J., Ifrim, I., Zhang, W.Y., 1999. Characterisation of patocytosis: endocytosis into macrophage surfaceconnected compartments. Eur. J. Cell Biol. 78, 91-99. (Pubitemid 29112470)
28. Lai, S.K., Hida, K., Man, S.T., Chen, C., Machamer, C., Schroer, T.A., Hanes, J., 2007. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a nonclathrin, non-degradative pathway. Biomaterials 28, 2876-2884. (Pubitemid 46482662)
29. Lorenza, R.M., Holzapfel, V., Musyanovych, A., Nothelfer, K., Walther, P., Frank, H., Landfester, K., Schrezenmeier, H., Mailander, V., 2006. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27, 2820-2828. (Pubitemid 43165751)
30. Lou, E., Fujisawa, S., Morozov, A., Barlas, A., Romin, Y., Dogan, Y., Gholami, S., Moreira, A.L., Manova-Todorova, K., Moore, M.A., 2012. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. PLoS ONE 7 (3), e33093.
31. Manconi, M., Isola, R., Falchi, A.M., Sinico, C., Fadda, A.M., 2007. Intercellular distribution of fluorescent probes delivered by vesicles of different lipidic composition. Colloid Surfaces B: Biointerfaces 57, 143-151. (Pubitemid 46671506)
32. McGowan, M., 2011. Tunneling nanotubes-Crossing the bridge. J. Cell Mol. Biol. 9, 11-18.
33. Müller, R.H., Mäder, K., Gohla, S., 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161-177. (Pubitemid 30326695)
34. Obermajer, N., Jevnikar, Z., Doljak, B., Sadaghiani, A.M., Bogyo, M., Kos, J., 2009. Cathepsin X-mediated b2 integrin activation results in nanotubes outgrowth. Cell. Mol. Life Sci. 66, 1126-1134.
35. Önfelt, B., Nedvetzki, S., Benninger, R.K., Purbhoo, M.A., Sowinski, S., Hume, A.N., Seabra, M.C., Neil, M.A., French, P.M., Davis, D.M., 2006. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J. Immunol. 177, 8476-8483. (Pubitemid 44893810)
36. Onfelt, B., Nedvetzki, S., Yanagi, K., Davis, D.M., 2004. Cutting edge: membrane nanotubes connect immune cells. J. Immunol. 173, 1511-1513. (Pubitemid 38971579)
37. Panyam, J., Sahoo, S.K., Prabha, S., Bargar, T., Labhasetwar, V., 2003. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D, Llactide-co-glycolide) nanoparticles. Int. J. Pharm. 262, 1-11. (Pubitemid 36966688)
38. Peixoto, F.S., Dias, P.M., Ramaldes, G.A., Vilela, J.M.C., Andrade, M.S., Cunha, A.S., 2005. Atomic force microscopy applied to the characterization of solid lipid nanoparticles. Microsc. Microanal. 11, 52-55. (Pubitemid 44699368)
39. Rodriguez-Boulan, E., Kreitzer, G., Musch, A., 2005. Organization of vesicular trafficking in epithelia. Nat. Rev. Mol. Cell Biol. 6, 233-247. (Pubitemid 40314924)
40. Ruenraroengsak, P., Cook, J.M., Florence, A.T., 2010. Nanosystem drug targeting: facing up to complex realities. J. Control. Rel. 141, 265-276.
41. Rustom, A., Saffrich, R., Markovic, I., Walther, P., Gerdes, H.H., 2004. Nanotubular highways for intercellular organelle transport. Science 303, 1007-1010. (Pubitemid 38209703)
42. Silva, A.H., Filippin-Monteiro, F.B., Mattei, B., Zanetti-Ramos, B.G., Creczynski-Pasa, T.B., 2012. In vitro biocompatibility of solid lipid nanoparticles. Sci. Total Environ. 432, 382-388.
43. Singh, R., Nalwa, H.S., 2011. Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J. Biomed. Nanotechnol. 7, 489-503.
44. Sowinski, S., Jolly, C., Berninghausen, O., Purbhoo, M.A., Chauveau, A., Köhler, K., Oddos, S., Eissmann, P., Brodsky, F.M., Hopkins, C., Onfelt, B., Sattentau, Q., Davis, D.M., 2008. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10, 211-219. (Pubitemid 351194051)
45. Suresh, S., 2007. Biomechanics and biophysics of cancer cells. Acta Biomater. 3, 413-438. (Pubitemid 46865787)
46. Teskač Plajnšek, K., Govedarica, B., Srčič, S., Pajk, S., Pečar, S., Kristl, J., 2011. A novel fluorescent probe for more effective monitoring of lipid nanoparticles for drug delivery within the cells. Int. J. Pharm. 416, 384-393.
47. Teskač, K., Kristl, J., 2010. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390, 61-69.
48. Unfried, K., Albrecht, C., Klotz, L.O., Von Mikecz, A., Grether-Beck, S., Schins, R.P.F., 2007. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1, 52-71. (Pubitemid 46570247)
49. Van Deurs, B., Peterson, O.W., Olsnes, S., Sandvig, K., 1989. The ways of endocytosis. Int. Rev. Cytol. 17, 131-177. (Pubitemid 20015266)
50. Veranic, P., Lokar, M., Schütz, G.J., Weghuber, J., Wieser, S., Hägerstrand, H., Kralj, S., Iglic, V., Iglic, A., 2008. Different types of cell-to-cell connections mediated by nanotubular structures. Biophys. J. 95, 4416-4425.
51. Villodi, A., 2004. Lysosomal storage disorders. Br. J. Haematol. 128, 413-431.
52. Wang, Y., Cui, J., Sun, X., Zhang, Y., 2011. Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ. 18, 732-742.
53. Watson, P., Jones, A.T., Stephens, D.J., 2005. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliv. Rev. 57, 43-61. (Pubitemid 39424063)
54. White, N.S., Errington, J.R., 2005. Fluorescence techniques for drug delivery research: theory and practice. Adv. Drug Deliv. Rev. 57, 17-42. (Pubitemid 39424062)
55. Xu, P., Gullotti, E., Tong, L., Highley, C.B., Errabelli, D.R., Hasan, T., Cheng, J.X., Kohane, D.S., Yeo, Y., 2009. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol. Pharm. 6, 190-201.
56. Yoo, J.W., Doshi, N., Mitragotri, S., 2011. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv. Drug Del. Rev. 63, 1247-1256.
57. Zhang, Y., 2011. Tunneling-nanotube: a new way of cell-cell communication. Commun. Integr. Biol. 4, 324-325.
58. Zhang, J., Campbell, R.E., Ting, A.Y., Tsien, R.Y., 2002. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3, 906-918. (Pubitemid 35477369)